FDA Clears Cerêve Device For Treating Insomnia Patients By Helping Them Get To Sleep Faster

The U.S. Food and Drug Administration (FDA) has granted commercial clearance for the CerêveSleep System, a prescription device that reduces latency to Stage 1 and Stage 2 sleep for people with insomnia.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news